CL2009001486A1 - Uso de compuestos derivados de fenilaminopirimidina para tratar neurofibroma plexiforme. - Google Patents
Uso de compuestos derivados de fenilaminopirimidina para tratar neurofibroma plexiforme.Info
- Publication number
- CL2009001486A1 CL2009001486A1 CL2009001486A CL2009001486A CL2009001486A1 CL 2009001486 A1 CL2009001486 A1 CL 2009001486A1 CL 2009001486 A CL2009001486 A CL 2009001486A CL 2009001486 A CL2009001486 A CL 2009001486A CL 2009001486 A1 CL2009001486 A1 CL 2009001486A1
- Authority
- CL
- Chile
- Prior art keywords
- phenylaminopyrimidine
- treat
- derived compounds
- plexiform neurofibroma
- neurofibroma
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Método para tratar neurofibroma plexiforme con un compuesto derivado de pirimidina.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7618508P | 2008-06-27 | 2008-06-27 | |
US10365008P | 2008-10-08 | 2008-10-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2009001486A1 true CL2009001486A1 (es) | 2010-04-16 |
Family
ID=41445287
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2009001486A CL2009001486A1 (es) | 2008-06-27 | 2009-06-25 | Uso de compuestos derivados de fenilaminopirimidina para tratar neurofibroma plexiforme. |
Country Status (18)
Country | Link |
---|---|
US (3) | US20110195975A1 (es) |
EP (1) | EP2291186A4 (es) |
JP (2) | JP2011526292A (es) |
KR (2) | KR20160011713A (es) |
CN (2) | CN102099038A (es) |
AU (1) | AU2009262214B9 (es) |
BR (1) | BRPI0914618A2 (es) |
CA (1) | CA2727737C (es) |
CL (1) | CL2009001486A1 (es) |
EA (2) | EA201500525A1 (es) |
IL (1) | IL209973A (es) |
MA (1) | MA32419B1 (es) |
MX (1) | MX2010013918A (es) |
NZ (1) | NZ590076A (es) |
SG (1) | SG192444A1 (es) |
TW (1) | TWI508728B (es) |
WO (1) | WO2009158447A2 (es) |
ZA (1) | ZA201009066B (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK3381943T3 (da) | 2012-07-25 | 2022-05-16 | Celldex Therapeutics Inc | Anti-kit-antistoffer og anvendelser deraf |
JP6768639B2 (ja) * | 2014-05-23 | 2020-10-21 | セルデックス セラピューティクス,インコーポレーテッド | 好酸球又はマスト細胞関連障害の治療 |
KR101894769B1 (ko) | 2017-12-05 | 2018-09-04 | 아주대학교산학협력단 | siRNA를 포함하는 신경섬유육종 예방 또는 치료용 조성물 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5521184A (en) | 1992-04-03 | 1996-05-28 | Ciba-Geigy Corporation | Pyrimidine derivatives and processes for the preparation thereof |
CO4940418A1 (es) | 1997-07-18 | 2000-07-24 | Novartis Ag | Modificacion de cristal de un derivado de n-fenil-2- pirimidinamina, procesos para su fabricacion y su uso |
GB0022438D0 (en) * | 2000-09-13 | 2000-11-01 | Novartis Ag | Organic Compounds |
GB0209265D0 (en) | 2002-04-23 | 2002-06-05 | Novartis Ag | Organic compounds |
CA2439440A1 (en) * | 2002-09-05 | 2004-03-05 | Emory University | Treatment of tuberous sclerosis associated neoplasms |
CA2629132C (en) * | 2005-12-06 | 2014-05-27 | Novartis Ag | Pyrimidylaminobenzamide derivatives for the treatment of neurofibromatosis |
WO2009100176A2 (en) * | 2008-02-07 | 2009-08-13 | Abbott Laboratories | Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor |
-
2009
- 2009-06-25 KR KR1020167001722A patent/KR20160011713A/ko not_active Application Discontinuation
- 2009-06-25 NZ NZ590076A patent/NZ590076A/xx not_active IP Right Cessation
- 2009-06-25 CA CA2727737A patent/CA2727737C/en not_active Expired - Fee Related
- 2009-06-25 EA EA201500525A patent/EA201500525A1/ru unknown
- 2009-06-25 BR BRPI0914618A patent/BRPI0914618A2/pt not_active IP Right Cessation
- 2009-06-25 SG SG2013049952A patent/SG192444A1/en unknown
- 2009-06-25 EP EP09770980A patent/EP2291186A4/en not_active Withdrawn
- 2009-06-25 JP JP2011516634A patent/JP2011526292A/ja active Pending
- 2009-06-25 CN CN2009801234742A patent/CN102099038A/zh active Pending
- 2009-06-25 US US12/996,891 patent/US20110195975A1/en not_active Abandoned
- 2009-06-25 KR KR1020107028646A patent/KR20110044945A/ko active Search and Examination
- 2009-06-25 AU AU2009262214A patent/AU2009262214B9/en not_active Ceased
- 2009-06-25 EA EA201071340A patent/EA022611B1/ru not_active IP Right Cessation
- 2009-06-25 CL CL2009001486A patent/CL2009001486A1/es unknown
- 2009-06-25 WO PCT/US2009/048554 patent/WO2009158447A2/en active Application Filing
- 2009-06-25 TW TW098121297A patent/TWI508728B/zh not_active IP Right Cessation
- 2009-06-25 MX MX2010013918A patent/MX2010013918A/es active IP Right Grant
- 2009-06-25 CN CN201610089818.4A patent/CN105726542A/zh active Pending
-
2010
- 2010-12-13 IL IL209973A patent/IL209973A/en not_active IP Right Cessation
- 2010-12-17 ZA ZA2010/09066A patent/ZA201009066B/en unknown
- 2010-12-27 MA MA33461A patent/MA32419B1/fr unknown
-
2013
- 2013-09-20 US US14/032,994 patent/US8933082B2/en not_active Expired - Fee Related
-
2014
- 2014-11-18 US US14/546,827 patent/US9345704B2/en not_active Expired - Fee Related
-
2015
- 2015-04-01 JP JP2015075280A patent/JP2015187104A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
KR20110044945A (ko) | 2011-05-03 |
IL209973A (en) | 2015-11-30 |
AU2009262214A1 (en) | 2009-12-30 |
TWI508728B (zh) | 2015-11-21 |
EA201500525A1 (ru) | 2015-11-30 |
JP2015187104A (ja) | 2015-10-29 |
MA32419B1 (fr) | 2011-06-01 |
EA201071340A1 (ru) | 2011-12-30 |
JP2011526292A (ja) | 2011-10-06 |
WO2009158447A2 (en) | 2009-12-30 |
US9345704B2 (en) | 2016-05-24 |
SG192444A1 (en) | 2013-08-30 |
US20150072992A1 (en) | 2015-03-12 |
NZ590076A (en) | 2012-11-30 |
US20140121214A1 (en) | 2014-05-01 |
US20110195975A1 (en) | 2011-08-11 |
IL209973A0 (en) | 2011-02-28 |
EA022611B1 (ru) | 2016-02-29 |
AU2009262214B2 (en) | 2014-12-11 |
EP2291186A4 (en) | 2011-06-22 |
KR20160011713A (ko) | 2016-02-01 |
CN105726542A (zh) | 2016-07-06 |
CA2727737A1 (en) | 2009-12-30 |
ZA201009066B (en) | 2011-08-31 |
TW201006472A (en) | 2010-02-16 |
CA2727737C (en) | 2016-08-23 |
EP2291186A2 (en) | 2011-03-09 |
AU2009262214B9 (en) | 2015-04-30 |
US8933082B2 (en) | 2015-01-13 |
CN102099038A (zh) | 2011-06-15 |
BRPI0914618A2 (pt) | 2017-06-06 |
WO2009158447A9 (en) | 2010-03-25 |
MX2010013918A (es) | 2011-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2570569T3 (es) | Compuestos de benzoxazepina como inhibidores de la PI3K y métodos de uso | |
UA110338C2 (en) | Chemical compounds | |
MX2010009765A (es) | Moleculas pequeñas que contienen boro como agentes anti-inflamatorios. | |
ME01665B (me) | Analozi buprenorfina | |
CR20140024A (es) | Compuestos inhibidores de metaloenzimas | |
CL2011000134A1 (es) | Compuestos derivados de aminofenoxiindazoles, inhibidores de c-met; composicion farmaceutica que comprende a estos compuestos; y su uso para tratar el cancer. | |
BRPI0921433A2 (pt) | uso de anticorpos anti-cs1 para o tratamento de linfomas raros | |
UY34177A (es) | Nuevos compuestos inhibidores de la fosfodiesterasa tipo 10a | |
CL2007001670A1 (es) | Uso de compuestos derivados de amina para el tratamiento de un trastorno mediado por citoquinas. | |
BRPI0914836A2 (pt) | conduto para transportar um efluente petrolífero | |
DOP2010000328A (es) | Inhibidores de bace | |
CO6842020A2 (es) | Inhibidores de la tirosina-quinasa de bruton | |
UY33929A (es) | Compuestos de ciclohexilo tetrasustituido como inhibidores de quinasas | |
MA32551B1 (fr) | Nouveaux composes utiles pour le traitement de maladies degeneratives et inflammatoires | |
CL2012000590A1 (es) | Proceso para preparar w-transaminasa (r)-selectiva. | |
BRPI1010937A2 (pt) | composto, uso de um composto, e, método para tratar câncer | |
EA201691430A1 (ru) | Лечение портальной гипертензии и восстановление функции печени с помощью l-орнитинфенилацетата | |
DK2293816T3 (da) | Fremgangsmåder til behandling af reumatoid arthritis | |
UY31770A1 (es) | Inhibidores de catepsina c | |
EA201170288A1 (ru) | Оксабициклогептаны и оксабициклогептены, их получение и применение | |
UY34165A (es) | ?compuestos aldh-2 mitocondriales humanos para el tratamiento de la adicción?. | |
UY32384A (es) | Nuevas bencenosulfonamidas como bloqueadores de canales de calcio | |
CR20140079A (es) | Aminoquinazolinas como inhibidores de quinasa | |
CL2011000098A1 (es) | Uso de una betadefensina de mamifero para tratar enfermedad inflamatoria. | |
BRPI0911077A2 (pt) | método para tratamento de biomassa |